Efficacy of Generic Bortezomib Used as a Part of CyBorD Regimen to Achieve Complete Response in Multiple Myeloma. ijmhs [Internet]. 2019 Feb. 4 [cited 2026 Oct. 23];9(1):247-51. Available from: http://www.innovativejournal.in/index.php/ijmhs/article/view/2431